Dipicolinic Acid
CAS 499-83-2
Dipicolinic Acid (CAS 499-83-2) is a pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 20868.88888888889 nM | 27 | - |
| - | MIC | 1.5938333333333334 ug.mL-1 | 12 | - |
| - | Potency | 5666.74 nM | 10 | - |
| - | Ki | 36733.333333333336 nM | 3 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Dipicolinic Acid used for in pharmaceutical contexts?
Dipicolinic Acid (CAS 499-83-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Dipicolinic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Dipicolinic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Dipicolinic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for 2,6-Dicarboxypyridine (Dipicolinic Acid) with EU status "permitted".
What clinical phase is Dipicolinic Acid in?
No phase 1-4 clinical development badge is rendered for Dipicolinic Acid because the matched compound identifier rows do not contain a max-phase value.